Federally Qualified Health Centers Can Expand Rural Access to Buprenorphine for Opioid Use Disorder in Arizona
Medication for Opioid Use Disorder (MOUD) is recommended, but not always accessible to those who desire treatment. This study assessed the impact of expanding access to buprenorphine through federally qualified health centers (FQHCs) in Arizona. We calculated mean drive-times to Arizona opioid treat...
Saved in:
Main Authors: | Benjamin R Brady (Author), Rachel Gildersleeve (Author), Bryna D Koch (Author), Doug E Campos-Outcalt (Author), Daniel J Derksen (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Guide to Expanding the Use of Buprenorphine Beyond Standard Initiations for Opioid Use Disorder
by: James C. Miller, et al.
Published: (2023) -
Opportunities and Challenges: Hepatitis C Testing and Treatment Access Experiences Among People in Methadone and Buprenorphine Treatment During COVID-19, Arizona, 2021
by: Beth E. Meyerson, PhD, et al.
Published: (2023) -
Opioid substitution treatment with sublingual buprenorphine in Manipur and Nagaland in Northeast India: what has been established needs to be continued and expanded
by: Sharma Charan, et al.
Published: (2009) -
Advances in the delivery of buprenorphine for opioid dependence
by: Rosenthal RN, et al.
Published: (2017) -
Applying Implementation Mapping to Expand a Care Coordination Program at a Federally Qualified Health Center
by: Kelsey S. Dickson, et al.
Published: (2022)